Yusuke Nakamura to Prostatic Neoplasms, Castration-Resistant
This is a "connection" page, showing publications Yusuke Nakamura has written about Prostatic Neoplasms, Castration-Resistant.
Connection Strength
0.226
-
Phase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancer. Cancer Sci. 2017 Jul; 108(7):1452-1457.
Score: 0.117
-
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy. Clin Cancer Res. 2016 Oct 01; 22(19):4890-4900.
Score: 0.108